MedPath

SUCRALFATE

SUCRALFATE SUSPENSION1 g/10 mL

Approved
Approval ID

187ce680-e3de-45cb-98f3-96e069804c62

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 24, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sucralfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-5299
Application NumberNDA019183
Product Classification
M
Marketing Category
C73594
G
Generic Name
Sucralfate
Product Specifications
Route of AdministrationORAL
Effective DateApril 1, 2011
FDA Product Classification

INGREDIENTS (7)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SUCRALFATEActive
Quantity: 1 g in 10 mL
Code: XX73205DH5
Classification: ACTIB
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SUCRALFATE - FDA Drug Approval Details